SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Date of Report (Date of Earliest Event Reported): March 19, 2003 (March 20, 2003)
ENDO PHARMACEUTICALS HOLDINGS INC.
|(State or other||(Commission File Number)||(I.R.S. Employer|
|jurisdiction of incorporation)||Identification No.)|
|100 Painters Drive|
|Chadds Ford, Pennsylvania||19317|
|(Address of principal executive offices)||(Zip Code)|
Item 7. Financial Statements and Exhibits.
|(a)||Financial Statements of Business Acquired.|
|(b)||Pro Forma Financial Information.|
|99.3||Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated March 20, 2003|
Item 9. Regulation FD Disclosure.
On March 20, 2003, the Registrant intends to make a slide presentation at the SG Cowen 23rd Annual Health Care Conference in Boston, Massachusetts, a copy of which presentation is filed herewith as Exhibit 99.1 and is incorporated herein by reference.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
|ENDO PHARMACEUTICALS HOLDINGS INC.|
|By:||/s/ CAROL A. AMMON|
|Name:||Carol A. Ammon|
|Title:||Chairman & Chief Executive Officer|
|Dated: March 19, 2003|
INDEX TO EXHIBITS
|99.1||Slide Presentation of Endo Pharmaceuticals Holdings Inc. dated March 20, 2003|